SEC Form 4
HCA Healthcare, Inc. (HCA) insider trading
In the 12 months to Oct 24, 2026, 5 HCA insiders reported open-market sales of $31.1M across 6 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $31.1M
- 6 filings · 5 insiders
- Open-market purchases
- $0
- 0 filings
Who traded HCA, and when
- Sale
HCA daily close from Oct 24, 2025 to Oct 23, 2026, between $361.32 and $545.13, last $469.03. 6 sale and 0 purchase filings by 5 insiders, marked at their filing dates. Samuel N. Hazen, CEO: sold $21.5M across 1 filing, first filed Feb 5, 2026, last Feb 5, 2026. Jennifer Berres, SVP & Chief Human Res. Officer: sold $4.1M across 1 filing, first filed Feb 12, 2026, last Feb 12, 2026. Michael R. McAlevey, EVP & Chief Legal & Admin Off.: sold $2.7M across 2 filings, first filed Nov 5, 2025, last Feb 18, 2026. Christopher F. Wyatt, SVP & Controller: sold $2.0M across 1 filing, first filed Feb 12, 2026, last Feb 12, 2026. Michael S. Cuffe, EVP and Chief Clinical Officer: sold $747.1K across 1 filing, first filed Feb 5, 2026, last Feb 5, 2026.
Largest mark · tap a row for others
Samuel N. Hazen · CEO
Sale $21,483,275
42,877 shares at $501.04 avg
Filed Feb 5, 2026 · traded Feb 3
Close on filing date $513.76
Samuel N. Hazen · CEO
CEO
$21.5M soldJennifer Berres · SVP & Chief Human Res. Officer
SVP & Chief Human Res. Officer
$4.1M soldMichael R. McAlevey · EVP & Chief Legal & Admin Off.
EVP & Chief Legal & Admin Off.
$2.7M soldChristopher F. Wyatt · SVP & Controller
SVP & Controller
$2.0M soldMichael S. Cuffe · EVP and Chief Clinical Officer
EVP and Chief Clinical Officer
$747.1K soldHas HCA Healthcare, Inc.'s CEO sold stock?
Yes. Samuel N. Hazen (CEO) sold 42,877 shares ($21.5M) in Feb 2026.
Open-market trades
6 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Samuel N. Hazen | CEO | $21.5M | — | 1 | — | |
| Jennifer Berres | SVP & Chief Human Res. Officer | $4.1M | — | 1 | — | |
| Michael R. McAlevey | EVP & Chief Legal & Admin Off. | $2.7M | — | 2 | — | |
| Christopher F. Wyatt | SVP & Controller | $2.0M | — | 1 | — | |
| Michael S. Cuffe | EVP and Chief Clinical Officer | $747.1K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Michael R. McAlevey EVP & Chief Legal & Admin Off. | Sale | 1,694 | $533.37 | $903.5K | 8,853 | |
traded | Jennifer Berres SVP & Chief Human Res. Officer | Sale | 8,020 | $514.58 | $4.1M | 11,993 | |
traded | Christopher F. Wyatt SVP & Controller | Sale | 4,000 | $505.00 | $2.0M | 44,379 | |
traded | Michael S. Cuffe EVP and Chief Clinical Officer | Sale | 1,500 | $498.09 | $747.1K | 30,003 | |
traded | Samuel N. Hazen CEO | Sale | 42,877 | $501.04 | $21.5M | 41,851 | |
traded | Michael R. McAlevey EVP & Chief Legal & Admin Off. | Sale | 3,892 | $473.79 | $1.8M | 3,487 |
GET /stocks/filings/vX/form-4?tickers=HCA&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"HCA"
],
"issuer_cik": "0000860730",
"owner_cik": "0001907875",
"accession_number": "0001193125-26-057701",
"form_type": "4",
"filing_date": "2026-02-18",
"period_of_report": "2026-02-13",
"issuer_name": "HCA Healthcare, Inc.",
"issuer_trading_symbol": "HCA",
"owner_name": "McAlevey Michael R",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP & Chief Legal & Admin Off.",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-02-18",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 1694,
"transaction_price_per_share": 533.3747,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 8853,
"transaction_value": 903536.7418,
"direct_or_indirect": "D"
},
{
"tickers": [
"HCA"
],
"issuer_cik": "0000860730",
"owner_cik": "0001793262",
"accession_number": "0001193125-26-049184",
"form_type": "4",
"filing_date": "2026-02-12",
"period_of_report": "2026-02-10",
"issuer_name": "HCA Healthcare, Inc.",
"issuer_trading_symbol": "HCA",
"owner_name": "Berres Jennifer",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "SVP & Chief Human Res. Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-02-11",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 4010,
"transaction_price_per_share": 503,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 16003,
"transaction_value": 2017030,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 57 records
- Option exercises6 records
- Tax withholding14 records
- Grants and awards16 records
- Gifts7 records
- Other14 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for HCA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.